Upload
kush-pathak
View
236
Download
0
Embed Size (px)
Citation preview
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
1/133
Presented by:Dr. Kush Pathak
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
2/133
Introduction
Classification of Precancerous lesions and
Conditions Detection techniques
Advanced diagnostic methods
Conclusion References
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
3/133
Oral cancer is sometimes preceded by clinically visible lesions
which are noncancerous to begin with and which have therefore
been termed precancerous or premalignant. WHO divided this
premalignant state into two:
Precancerous lesions
Precancerous condition ( Pindborg 1980)
The ability to diagnose premalignant state is critical to the battleagainst oral cancer, so that it can be managed conservatively with
minimal surgical morbidity and 100% survival.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
4/133
The most important and widely used method of evaluating the
malignant potential of oral precancerous lesions and conditions is
by a conventional microscopical study of epithelial dysplasia.
Advances in molecular diagnosis suggest that genetic markers of
precancerous changes are likely detectable before clinical and
histopathologic changes can be identified making it necessary todevelop these methods for early diagnosis and treatment.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
5/133
Precancerous lesion - (WHO 1978) is a morphologically alteredtissue in which cancer is more likely to occur than in its apparently
normal counterpart.
Clinical classification Leukoplakia
Erythroplakia Proliferative Verrucous leukoplakia
palatal keratosis with reverse smoking
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
6/133
Histological classification Squamous epithelial dysplasia
Squamous cell carcinoma
Solar keratosis
Precancerous condition: (WHO 1978) is defined as a generalizedstate associated with a significantly increased risk of cancer.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
7/133
Sideropenic dysphagia
lichen planus
Oral submucous fibrosis
Syphilis
Discoid lupus erythematosus
Xeroderma pigmentosa
Epidermolysis bullosa
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
8/133
Clinical examination Diagnostic adjuncts
Cytology
Brush cytology
Liquid cytology
Tissue fluorescence
Vital staining Diagnostic methods
Biopsy Fine needle aspiration
Sentinel node biopsy
Imaging
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
9/133
Cytochemical and molecular methods Nucleolar organizing regions
Abnormal DNA segregation (DNA aneuploidy)
Loss of heterozygosity
Advanced Molecular methods Molecular methods
Polymerase chain reaction
Filter hybridization
In situ hybridization
Fluorescent in situ hybridization
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
10/133
Comparative genomic hybridization
Complemantry DNA (cDNA) microarrays
Flow cytometry
Immunologic methods Immunohistochemistry
Immunofluorescency
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
11/133
Should include a thorough head and neck & intraoral examination,
with examination of the lymph nodes and visual examination,
palpation of the oral mucosa.
The location, size, border, color and surface characteristics of the
lesion should be noted.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
12/133
A variety of aids to the diagnosis of oral precancerous and
cancerous lesions have been developed in past few years. Increased
use of these adjunctive tools by dentists would likely improve early
cancer detection. However proper case selection and correct
performance of the test itself is critical to the sensitivity and
specificity of its result.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
13/133
This is the study of cells which exfoliate or abrade from the body
surface.
Procedure:- Involves stroking the lesion gently but firmly with a wet wooden
tongue blade or cotton tip applicator.
The collected cells are smeared on a frosted slide and immediately
fixed with alcohol ether. After drying the glass slide is packagedand sent to an oral pathology laboratory for staining.
Cell slides are examined for benignancy or malignancy.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
14/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
15/133
The Cytological smear falls in one of the five classes
Class I (normal) indicates that only normal cells were seen Class II (atypical) indicates the presence of minor atypia but no
evidence of malignant changes
Class III (indeterminate) cells display wider atypia that may besuggestive of cancer, may represent precancerous lesions orcarcinoma in situ. Biopsy is recommended in such cases
Class IV (suggestive of cancer) few cells with malignantfeatures or many cells with borderline. Biopsy is mandatory.
Class V (positive of cancer) cells are obviously malignant.Biopsy is mandatory.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
16/133
Advantage: Quick, simple, painless and bloodless procedure Helps as a check against false negative biopsies Especially helpful in follow-up detection of recurrent carcinoma in
previously treated cases Screening lesion where biopsy is not warranted
Disadvantages: Presence and extent of invasion can not be assessed
Scarcity of viable surface cells Biopsy is indicated in all clinically suspicious lesions even on
negative result Has high false negative results
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
17/133
Introduced in 1999 as an alternative to conventional Exfoliative
cytology for suspicious epithelial lesions.
Procedure :
Transepithelial cell samples are obtained by twirling a patented spiralshaped stiff nylon bristle brush on the lesion.
Collected cells are transferred to a bar coded, clear glass slide and a
supplied pouch of alcohol fixative is immediately poured over the
slide.
The specimen is mailed. Results of brush cytology specimens are
classified into one of four categories:-
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
18/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
19/133
Inadequateincomplete transepithelial sample Negativeno epithelial abnormality Atypicalabnormal epithelial changes Positive definitive cellular evidence of epithelial dysplasia or
carcinoma
For atypical and positive results follow up scalpel biopsy is
recommended. In case of a negative result clinical follow up ofpersistent oral lesions is recommended.
Scuibba et al reported 100% sensitivity with 100% specificity for
positive results and 92.9% specific results in 945 patients.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
20/133
Advantages: Full thickness sample Easy to use Useful alternative in patients who refuse a scalpel biopsy
In combination with vital staining may be useful for samplingmultiple areas of large lesions or in follow up patients.Disadvantages:
Specimens have to be processed in commercial processinglaboratory
Not all of the harvested transepithelial cells are transferred to theglass slide
Expensive
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
21/133
Provides a clearer and more attractive presentation.
Procedure: Transepithelial cells are harvested with a nylon bristle brush that is
then immersed and twirled in a liquid preservative container; the
brush can be disposed of or included in the specimen.
The liquid container is sent to the oral pathology laboratory where
a patented machine filters the harvested cells from debris and lays
the cells in monolayer on a glass slide, followed by staining and
examination.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
22/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
23/133
Advantages: Better representation of collected lesional cells
Easier interpretation since there is a monolayer of cells with
elimination of blood and debris
False positive and false negative results lessened.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
24/133
Used in combination with conventional visual oral mucosal
examination by healthcare providers to improve identification,
evaluation and monitoring of oral mucosal abnormalities. Several
different products designed for this technique have been marketed
including:
Vizilite, now available as Vizilite plus or vizilite with Tblue
marking system. MIcrolux DL
VELscope (visually enhanced lesion scope)
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
25/133
Vizilite Is a single use product that consists of an acetic acid rinse, retractor
and light stick. The patient rinses with vizilite acetic acid solution
and expectorates.
Acetic acid wash helps to remove surface debris and causes theepithelial cells to dehydrate slightly, increasing the prominence of
their nuclei.
The vizilite light stick is activated by bending until the innercapsule breaks.
The examiner shakes until it glows (activated chemiluminescence)
then inserts the light stick into the hollow end of the retractor.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
26/133
After dimming the lights, the oral cavity is examined using vizilite.Under blue whit illumination normal epithelium appears lightbluish in color, whereas abnormal epithelium appears distinctlywhite.
Vizilite plus: Consists of the same device packaged together with atolonium chloride solution. The stain is intended for use as amarking dye to help highlight lesions identified with light source.
Velscope: is an alternating current powered portable, reusablelight source and uses filters to block the reflected blue light to allowthe visualization of the natural tissue fluorescence.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
27/133
It is intended to be used as an adjunct to traditional oral
examination to enhance the visualization of oral mucosal
abnormalities that may not be apparent bynaked eye.
It is intended to be used by surgeons to identify diseased tissue
around clinically apparent lesion and thus aid in determining the
appropriate margin for surgical excision.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
28/133
The clinician is then able to differentiate different fluorescence
response ofnormal and abnormal tissue. Healthy tissue appears as
bright apple green glow while suspicious regions are identified by a
loss of fluorescence which thus appears dark.
In a study by Lane et al(2006) using histology as gold standard, the
device achieved a sensitivity of 98% and a specificity of 100% . Theauthors stated that this device has a potential as an adjunct to
convention white light screening.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
29/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
30/133
Advantage: Vizilite is simple to use
VELscope is portable, multiuse device and simple to use
Disadvantage: Vizilite plus is costly and light stick can only be activated once
VELscope unit is expensive and its durability has not been proven
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
31/133
Toludine blue or tolonium chloride.
In 1964, Nibel amd Chomet first reported on the use the use oftoludine blue as a vital tissue stain to aid in the early detection of
oral precancerous and malignant lesions.
The chemical name of the dye used is toludine chloride. It is a basicmetachromatic stain that binds to the DNA.
Although not cancer specific, it stains mitochondrial DNA, alteredDNA in Premalignant/malignant lesions and cells with increasedamounts of DNA.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
32/133
The practitioners swab the blue dye onto a suspicious oral lesionand based on its retention and changes in blue tint, determine with
greater reliability whether to proceed to biopsy.
Studies from 1964 to 1992, show that toludine blue exhibitsensitivity that ranged from 86% to 100% with a specificity rangingfrom 63% to 100%.
Recent studies have also shown that TB positivity is higher in OPL
that show loss of heterozygosity at chromosome regions associatedwith development of squamous cell carcinoma (3p,17p).
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
33/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
34/133
Despite the growing number of adjuncts available to assist in theclinical detection of lesions with uncertain biologic potential,surgical biopsy remains by far the most popular method ofobtaining a final tissue diagnosis.
Once a diagnosis is established, additional studies (includingimaging modalities) may be needed to determine the stage ofdiseases and to guide the treatment plan development.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
35/133
It is the removal of tissue from the living organism for the purposesof microscopic examination and diagnosis. The different methods ofbiopsy are:Excision biopsy: The goal of excision biopsy is to obtain theentire abnormality for histopathologic examination and toprovide definitive treatment by the total removal of the lesion.Adequate deep and lateral margins of normal appearing tissuemust be excised to ensure that no remnants of the lesionremain as a potential source of recurrence. It is reserved forclinically benign and precancerous mucosal lesions that areless than 2 cm in diameter.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
36/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
37/133
Incisional Biopsy Most suspicious lesions of the oral cavity arediagnosed through an incision biopsy, where a portion of theabnormal surface tissue is removed for histopathologicexamination.
The tissue samples should include the most clinically suspiciousportion of the lesion, including areas of erythroplakia, speckledleukoplakia, surface granularity or ulceration.
Application of TB stain may be useful in highlighting suspiciousareas.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
38/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
39/133
Punch biopsy - Punch is a soft tissue sampling instrument having a circular cutting
edge of varying diameter.
Deep biopsies in the areas like palate can be relatively simple to
obtain. But the disadvantages are the difficulty in controlling the sample
depth and necessary subsequent use of scalpel or scissors.
The tissue sample should be studied histopatholgically for epithelialdysplasia which is assigned to histopathological changes associatedwith an increases risk of malignant development. The individualcellular changes are referred to as atypia.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
40/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
41/133
The criteria used for diagnosing epithelial dysplasia (Pindborg et al1997) are:
Loss of polarity of basal cells
The presence of more than one layer of cells having a basaloid
appearance
Increased nuclear cytoplasmic ratio Drop shaped rete ridges
Irregular epithelial stratification
Increase number of mitotic figures
Mitotic figures that are abnormal in form
The presence of mitotic figures in the superficial half of the
epithelium
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
42/133
Cellular and nuclear pleomorphism
Nuclear hyperchromatism
Enlarged nuclei
Loss of intercellular adherence
Keratinization of single cell or cell groups in the prickle cell layer
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
43/133
Brandwein Gensler et al 2005 proposed a histologic risk assessmentsystem based on:
Perineural invasion greater than 1mm involving nerves
Lymphocytic response Worst pattern of invasion at interface
Imaging Evaluation of deep tissue involvement of oral cancer,presence of cervical lymphadenopathy and future evaluation of
primary tumor often requires use of several imaging modalities.
Imaging options include panoramic radiography, CT, MRI andpositron emission tomography.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
44/133
CT scan with intravenous contrast is the most common imagingmodalityused in the assessment ofdeep tissue extension of tumorsof oral cavity.
Advantage: Clearly demonstrates bone changes and tumor invasion More sensitive than MRI for lymphadenopathy Lower cost and good soft tissue contrast Better tolerated than MRI by patients
Disadvantage: Radiation dose Beam hardening artifact attributable to dental amalgam
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
45/133
MRI is superior in providing soft tissue details has multiplanarimaging capability and can better demonstrate intracranialextension of the tumor.
Disadvantage: Bony details are not clear Imaging times are longer Can not be used in patients who can not easily lie still or are
claustrophobic
Ultrasound can help in evaluation of neck nodes. However boneinvolvement can not be assessed as bone does not transmit sound.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
46/133
Sentinel node biopsy This procedure is intended to identify micrometastatic disease
within a sentinel node considered most likely to drain the tumor
bed and receive initial metastatic deposits from the primary
malignancy.
Represents a less invasive means of providing staging information
for the patient with oral cancer. So that not all the patients have to
undergo lymphadenopathy.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
47/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
48/133
Procedure Preoperative lymphoscintigraphy
Intraoperative lymphatic mapping
Excision of sentinel lymph nodes
Pathologic evaluation of sentinel lymph nodes
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
49/133
Recent advances in molecular studies show that alterations at DNA
level precede microscopic morphologic changes in pre cancer and
cancer.
Evaluation of these markers may help in early characterization of
oral epithelial dysplasia and squamous cell carcinoma.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
50/133
Nucleolar organizing regions: These are loops of ribosomal DNA located on the short arms of
chromosome 13,14,15,21 and 22 & are associated with acidic nonhistonic proteins that can be visualized by silver stainingtechniques.
Number and size of AgNORs correlate positively with cellularproliferation.
Mean AgNOR counts differ significantly between nondysplasticclinical leukoplakia with a sensitivity of 75 %.
Limitation with the technique includes the time and effort requiredto perform the study manually as well as staining variability andcounting subjectivity.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
51/133
DNA aneuploidy - (abnormal DNA segregation)
Abnormal chromosomal segregation resulting in aneuploidy can be
a marker for neoplastic transformation. Studies have reported an
association of ploidy status in dysplastic lesions with progressionrisk of oral pre cancer.
Lowest risk was associated with diploid lesions, tetreploid lesions
had intermediate risk and aneuploid lesions show greater risk.
(Lipmann SM, Hong WK 2001)
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
52/133
Accordingly a staging system of oral PML was proposed by Zangand Rosin with both pathologic and genetic findings.
P1 no or mild dyslasia, P2 moderate dysplasia, P3 severe dysplasiaG1 low risk, G2 intermediate, G3 high risk
Stage (cancer risk) Pathology P % genetic Gpattern
1 P1+G1
2 P2+G1,P1+G2,P2+G2
3 P3+G1,P3+G2, ANY P withG3
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
53/133
DNA alteration (loss of heterozygosity) The progression of oral epithelium from a benign to malignant
process begins at genetic level and is ultimately expressed at thecellular and clinical level.
Carcinogenesis does not result from a single area of DNA damage
but is a multistep process that requires an accumulation ofseveralDNA alterations collectively resulting in an uncontrolled neoplastic
growth.
Recent studies show that loss of allelic balance or LOH inprecancerous lesions is found in the 3p and 9p regions.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
54/133
For a given lesion the risk for progression to cancer can be
classified into
Low risk if no LOH is found.
Intermediate if LOH at 3p & 9p is found.
High if LOH at 3p & 9p is found along with additional genetic
damages.
The diagnosis of cancer and many other diseases is fundamentally
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
55/133
The diagnosis of cancer and many other diseases is fundamentallybased on the microscopic study of cells and tissues and remains thestandard by which all other diagnostic tests are measured.
The methods include
Molecular methods Polymerase chain reaction Filter hybridization
In situ hybridization
Fluorescent in situ hybridization
Comparative genomic hybridization
Complemantry DNA (cDNA) microarrays
Flow cytometry
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
56/133
Immunologic methods Immunohistochemistry
Immunofluorescency
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
57/133
DNA & RNA extraction: Currently all pathologic materials aresuitable for nucleotide extraction.
The steps involved in DNA extraction are:
Lysis of the cell usually performed with a detergent such assodium dodecy sulfate.
Proteniase K is used to both release the DNA from thechromatin and to destroy DNAases. DNAases can also bedestroyed through their heat sensitivity(65 degree for 15 min)
or with high concentration of EDTA. Cellular macromolecules are removed by extraction of the
sample in phenol or chloroform or both, which also functionsto remove any excess proteinase.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
58/133
After this extraction step, the DNA is concentrated byethanolprecipitation in the presence of acetate salts.
The DNA is then brought into the solution with a buffer or
distilled water and its concentration is assessed bymeasurement of its optical density of the solution at awavelength of 260nm.
The sample is then ready for further processing or it can bestored for long periods of time. If stored for a period up to 1
year, a 4 degree C refrigerator is sufficient, but for longerperiod a 20 degree C freezing is required.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
59/133
The steps involved in RNA extraction are
RNA extraction is complicated by the need to removeubiquitously present RNAases which may be endogenous or
exogenous, or both Guanidium isothiocyanate (GITC) is the most effective reagent
for RNA extraction.
RNA needs to store at much lower temperature of70 degreeC.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
60/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
61/133
A probe refers to a stretch of nucleotides that is used to detect a
specific region of DNA or RNA.
Those derived from native DNA are known as genomic probes and
may include both the exons and introns.
A probe derived from RNA is a cDNA probe and recognizes only
exons.
Oligonucleotide probes are formed in the laboratory and are much
shorter that the other two.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
62/133
Probes need to be further manipulated by the incorporation of a
label, allowing for the detection of the specific binding of the probe
to the target.
The initial labeling step is performed before hybridization.
The various methods of labeling are
Nick translation
Random hexamer priming End labeling
Polymerase chain reaction
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
63/133
For autoradiographyradioactive labeled probes.
Nonradioisotope labeling (digoxigenin or biotin) - Offers safe work
environment, faster signal detection and are easier to use than
radiolabeled probes.
Digoxigenin labeled probes - detected with alkaline phosphatase
conjugated, anti digoxygenin antibody.
Biotin labeled probes - detected by use of a streptavidin alkaline
phosphatase conjugate system.
A third method for visualization is through chemiluminescence, which
can be detected either luminometrically or on photographic film.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
64/133
PCR is an exponentially progressing synthesis of the defined target
DNA sequences in vitro.
Was introduced in 1983 by Kary mullis for which he received
Nobel prize in 1993 in chemistry.
Through this, a single piece of DNA can be used to generate infinite
supply of identical copies for a variety of research, clinical, forensic
and commercial purposes.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
65/133
1) Target DNA - contains the sequence to be amplified.2) Pair of Primers - oligonucleotides that define the sequenceto be amplified.
4) Thermostable DNA Polymerase - enzyme that catalyzes thereaction (Taq Polymerase)
5) Mg++
ions - cofactor of the enzyme
6) Buffer solution maintains pH and ionic strength of thereaction solution suitable for the activity of the enzyme
3) dNTPs - deoxynucleotidetriphosphates: DNA building blocks.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
66/133
THERMOCYCLERPCR tube
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
67/133
Denature (heat to 95oC)
Lower temperature to 56oCAnneal with primers
Increase temperature to 72oC
DNA polymerase + dNTPs
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
68/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
69/133
Classification of organisms Genotyping Molecular archaeology Mutagenesis
Mutation detection Sequencing Cancer research Detection of pathogens DNA fingerprinting
Drug discovery Genetic matching Genetic engineering Pre-natal diagnosis
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
70/133
Basic Research Applied Research
Genetic matching Detection of pathogens Pre-natal diagnosis DNA fingerprinting
Gene therapy
Mutation screening Drug discovery Classification of organisms Genotyping
Molecular Archaeology Molecular Epidemiology Molecular Ecology Bioinformatics Genomic cloning Site-directed mutagenesis
Gene expression studies
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
71/133
1. Reverse transcription PCR,2. Nested PCR,3. In situ PCR,4. Competitive PCR,5.
Single cell PCR,6. Immuno PCR,7. Inverse PCR,8. Anchored PCR,9. Asymmetrical PCR
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
72/133
Refers to the pairing of complementary RNA or DNA strands to
produce a double stranded nucleic acid.
All hybridization methods use a radio labeled DNA or RNA probe
that binds to the target DNA or RNA of interest, permitting
visualization.
The target molecule can be either immobilized in a membrane
(blotting) or examined in tissue sections (in situ).
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
73/133
This method was first described by Southern in 1975.
This involves the transfer or blotting of DNA fragments onto a
membrane.
Southern blotting is a technique which allows the detection of a
specific DNA sequence (gene or other) in a large, complex sample
of DNA (e.g. cellular DNA).
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
74/133
Whatman 3mm paper is the worlds most widely used blottingpaper. This acceptance and usage is due to the high quality, purityand consistency that are relied upon by researchers doing Southern,Northern and Western transfers.
A medium thickness paper (0.34 mm) is used extensively inelectrophoresis for lifting of sequencing gels.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
75/133
Filter Paper
Another Filter paper
Gel Matrix
Nitrocellulose membrane
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
76/133
Cut two pieces of filter paper and a piece of nitrocellulosemembrane to an appropriate size, and soak them in transfer buffer.
Place a piece of buffer soaked filter paper over the gel.
Flip the gel over, Place the buffer soaked nitrocellulose membraneagainst the exposed gel.
Place the second piece of buffer soaked filter paper on the
nitrocellulose membrane (covering it)
Check to see that there are no bubbles between the membrane andthe gel.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
77/133
1. The mixture of molecules is separated.
2. The molecules are immobilized on a matrix.
3. The probe is added to the matrix to bind to the molecules.
4. Any unbound probes are then removed.
5. The place where the probe is connected corresponds to the
location of the immobilized target molecule.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
78/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
79/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
80/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
81/133
Gene discovery
Mapping
Evolution
Development studies
Diagnostics and forensics.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
82/133
Is an RNA blotting technique which was developed in 1977 by
Alwine et al.
It was named after the Southern blotting technique.
Northern blot analysis allows a direct comparison of the messenger
RNA abundance between samples on a single membrane.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
83/133
1. RNA is isolated from several biological samples (e.g. various tissues,various developmental stages of same tissue etc.)RNA is more susceptible to degradation than DNA.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
84/133
2. Samples are loaded on gel and the RNA samples are separatedaccording to their size on an agarose gel.
The resulting gel following after the electrophoresis run.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
85/133
3. The gel is then blotted on a nylon membrane or a nitrocellulosefilter paper by creating the sandwich arrangement.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
86/133
4. The membrane is placed in a dish containing hybridization bufferwith a labeled probe.
5. The membrane is washed to remove unbound probe.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
87/133
6. The labeled probe is detected via autoradiography or via achemiluminescence reaction (if a chemically labeled probe isused). In both cases this results in the formation of a dark band onan X-ray film.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
88/133
A standard for the direct study of gene expression at the level of mRNA
(messenger RNA transcripts).
Detection of mRNA transcript size
Study RNA degradation Study RNA splicing - can detect alternatively spliced transcripts
Study RNA half-life
Study IRES (internal ribosomal entry site) - to remove possibility of RNA
digestion vs. 2nd cistron translation.
Often used to confirm and check transgenic / knockout mice (animals)
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
89/133
Often radioactivity is used. This prevents ease of performing it, use and
disposal.
The whole process of northern blotting takes a long time usually, from
sample preparation through to detection.
If RNA samples are even slightly degraded by RNases, the quality of the
data and quantization of expression is quite negatively affected.
The standard northern blot method is relatively less sensitive than nuclease
protection assays and RT-PCR. Detection with multiple probes is a problem. Often, the membranes must
be stripped before hybridization and detection with a second probe.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
90/133
Is a similar technique used to identify and locate proteins based ontheir ability to bind to specific antibodies.
Western Blot gives information on the: size of protein & expressionamount of protein.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
91/133
Steps :1. A protein sample is subjected to electrophoresis on anSDS-polyacrylamide gel.2. Electro blotting transfers the separated proteins from thegel to the surface of a nitrocellulose membrane.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
92/133
3. The blot is incubated with a generic protein (such as milk proteins)which binds to any remaining sticky places on the nitrocellulose.
4. An antibody that is specific for the protein of interest (the primaryantibody - Ab1) is added to the nitrocellulose sheet and reacts withthe antigen.
Only the band containing the protein of interest binds theantibody, forming a layer of antibody molecules .
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
93/133
5. Following several rinses for removal of non-specifically bound Ab1,the Ab1-antigen complex on the nitrocellulose sheet is incubatedwith a second antibody (Ab2), which specifically recognizes the Fcdomain of the primary antibody and binds it.
Ab2 is radioactively labeled, or is covalentlylinked to a reporter enzyme, which allows tovisualize the protein-Ab1-Ab2 complex.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
94/133
The confirmatory HIV test employs a Western blot to detect anti-
HIV antibody in a human serum sample.
A Western blot is also used as the definitive test for Bovine
spongiform encephalopathy (BSE, commonly referred to as 'mad
cow disease').
Some forms of Lyme disease testing employ Western blotting.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
95/133
Is a technique used to examine DNA and RNA in their normaltopographic surroundings.
In situ hybridization presents a unique set of problems as thesequence to be detected will be at a lower concentration, be maskedbecause of associated protein, or protected within a cell or cellularstructure.
Therefore, in order to probe the tissue or cells of interest one has to
increase the permeability of the cell and the visibility of thenucleotide sequence to the probe without destroying the structuralintegrity of the cell or tissue.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
96/133
a) Frozen sections - Fresh tissue is snap frozen (rapidly put into a -80
freezer) and then frozen embedded in a special support medium for
thin cryosectioning. The sections are lightly and rapidly fixed in 4%
paraformaldehyde just prior to processing for hybridization.b) Paraffin embedded sections - Sections are fixed in formalin as one
would normally fix tissues for histology and then embedded in wax
(paraffin sections) before being sectioned
c) Cells in suspension - Cells can be cytospun onto glass slides and
fixed with methanol
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
97/133
Oligonucleotide probes
Single stranded DNA probes.
Double stranded DNA probes
RNA probes (cRNA probes or riboprobes)
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
98/133
A process which vividly paints chromosomes or portions ofchromosomes with fluorescent molecules.
Identifies chromosomal abnormalities.
Aids in gene mapping, toxicological studies, analysis ofchromosome structural aberrations, and ploidy determination.
Used to identify the presence and location of a region of DNA or
RNA within morphologically preserved chromosome preparations,fixed cells or tissue sections.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
99/133
Advantage:
Less labor-intensive method for confirming the presence of a DNA
segment within an entire genome than other conventional methods
like Southern blotting.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
100/133
Denature the chromosomes
Denature the probe
Hybridization
Fluorescence staining
Examine slides or store in the dark
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
101/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
102/133
Detection of high concentrations of base pairs.
Also used in germ cell or prenatal diagnosis of conditions such as
aneuploidies.
Telomeric probes define the terminal boundaries of chromosomes. Used in research of chromosomal rearrangements and deletions
related to cell aging or other genetic abnormalities.
Application in cytogenetics - can detect submicroscopic deletions
and cryptic translocations of genes associated with unexplainedmental retardation and miscarriages.
FISH can be used in the study of transgenic animals.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
103/133
In 1986, Hector Battifora first introduced the so-called sausage orMulti Tumor Tissue Block, where up to 100 separate tissues wereprocessed together in one single paraffin wax block.
Also known as DNA Chip.
Allows simultaneous measurement of the level of transcription forevery gene in a genome (gene expression).
Microarray detects mRNA, or rather the more stable cDNA
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
104/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
105/133
Start with individual genes, e.g. the ~6,200 genes of the yeast
genome.
Amplifyall of them using polymerase chain reaction (PCR).
Spot them on a medium, e.g. an ordinary glass microscope
slide.
Each spot is about 100 m in diameter. Spotting is done by a robot.
Complex and potentially expensive task.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
106/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
107/133
Ngai Lab arrayer , UC Berkeley Print-tip head
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
108/133
Building the chip:
MASSIVE PCR PCR PURIFICATIONAND PREPARATION
PREPARING
SLIDES PRINTING
RNA preparation:CELL CULTURE
AND HARVEST
RNA ISOLATION
cDNA PRODUCTION
Hybing the chip:
ARRAY HYBRIDIZATION
PROBE LABELING DATA ANALYSIS
POST PROCESSING
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
109/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
110/133
Pins collect cDNAfrom wells
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
111/133
384 wellplate
Contains cDNAprobes
Glass Slide
Array of bound cDNA probes
4x4 blocks = 16 print-tip group
Print-tip
group 6
cDNA clonesSpotted in duplicate
Print-tipgroup 1
from wells
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
112/133
Measuring transcript abundance (cDNA arrays);
Genotyping;
Estimating DNA copy number (CGH);
Determining identity by descent (GMS);
Measuring mRNA decay rates;
Identifying protein binding sites;
Determining sub-cellular localization of gene products;
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
113/133
Flow cytometry is a technology that simultaneouslymeasures and thenanalyzes multiple physical characteristics of single particles, usually
cells, as they flow in a fluid stream through a beam of light. The
properties measured include a particles relative size, relative
granularity or internal complexity, and relative fluorescence intensity.
These characteristics are determined using an optical-to-electronic
coupling system that records how the cell or particle scatters incident
laser light and emits fluorescence.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
114/133
Cytometry Localization of antigen is
possible Poor enumeration of cell
subtypes
Limiting number ofsimultaneous measurements
Flow Cytometry Cannot tell you where
antigen is. Can analyze many cells in a
short time frame.
Can look at numerousparameters at once.
Instrument Overview
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
115/133
LASER SOURCE
Fluidic system
DetectorOptical filters
Computer
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
116/133
Interrogation Point
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
117/133
When a solution is injected into a flow cytometer the particles are
randomly distributed in three-dimensional space.
The sample must therefore be ordered into a stream of single
particles. That can be interrogated by the machines detection
system. This process is managed by the fluidics system.
Hydrodynamic Focusing
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
118/133
Here we see how the sample is
transported through the interrogation
point. For accurate data collection, it is
important that particles or cells are
passed through the laser beam one at
a time.
Sheath fluidCentral Core
Single flow
y y g
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
119/133
After hydrodynamic focusing, each particle passes through beamsof light.
The laser are the most commonly used light sources in modern flow
cytometry.
It gives information about the particles by forward scatteringChannel and Side scattering channel.
The detectors used in flow cytometry is PhotomultiplierTube(PMTs).
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
120/133
As a cell passes through the laser, itwill refract or scatter light at all
angles.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
121/133
In most cytometers, a blocking bar
(called an obscuration bar) is placed in
front of the forward scatter detector.
The obscuration bar prevents any of
the intense laser light from reaching
the detector. As a cell crosses the
laser, light is scattered around the
obscuration bar and is collected by thedetector.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
122/133
Small cells produce a smallamount of forward scatter andlarge cells produce a largeamount of forward scatter, themagnitude of the voltage pulserecorded for each cell isproportional to the cell size.
Side Scatter
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
123/133
The side scatter channel (SSC) provides information about the
granular content within a particle.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
124/133
This side-scattered light is focusedthrough a lens system and is collected bya separate detector, usually located 90
degrees from the lasers path.The signals collected by the side-scatterdetector
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
125/133
The fluorescent light travelsalong this path, it is directedthrough a series of filters andmirrors, so that particularwavelength ranges aredelivered to the appropriatedetectors.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
126/133
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
127/133
When light hits a photo detector a small current (a few
microamperes) is generated.
Its associated voltage has an amplitude proportional to the total
number of light photons received by the detector.
This voltage is then amplified by a series of linear or logarithmic
amplifiers, and by analog to digital convertors (ADCs), into
electrical signals large enough (510 volts) tobe plottedgraphically.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
128/133
Support a diagnosis of malignancy when the morphologic
changes are equivocal
Subclassify lesions of borderline malignancy
Provide prognostic information independent of stage and
grade
Monitor response to therapy
Establish development of tumor relapse
Establish the origin of synchronus or metachronus tmors
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
129/133
Neoplasia
Infectious disease
Hereditary disease
Identity determination
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
130/133
The practice of pathology is currently undergoing significant change, inlarge part due to advances in the analysis of DNA, RNA, and proteins intissues.
These advances have permitted improved biologic insights into manydevelopmental, inflammatory, metabolic, infectious, and neoplastic
diseases. Moreover, molecular analysis has also led to improvements in the
accuracy of disease diagnosis and classification. It is likely that, in thefuture, these methods will increasingly enter into the day-to-day diagnosisand management of patients.
The pathologist will continue to play a fundamental role in diagnosis andwill likely be in a pivotal position to guide the implementation andinterpretation of these tests as they move from the research laboratory intodiagnostic pathology.
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
131/133
ABC of clinical genetics by Helen M Kingston
Textbook of surgical pathology by Ackerman
Advanced diagnostic methods in oral and maxillofacial pathology:
molecular methods: journal of oral surg, oral med,oral path: dec 2001
Textbook of diagnostic molecular pathology
www.molecularstation.com
Textbook of oral pathology by Shafer
Advances in detection and diagnosis of oral precancerous and cancerouslesion: clinic of north America 2006
http://www.molecularstation.com/http://www.molecularstation.com/http://www.molecularstation.com/http://www.molecularstation.com/http://www.molecularstation.com/http://www.molecularstation.com/8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
132/133
Application of cytology and molecular biology in diagonising malignant
oral lesions: molecular cancer 2006
Role of oral health care specialists in the diagnostic purpose of oral cancer:M Akhar; AEGIS series
Review of oral premalignant lesions: Crit Rev Biol Med 2003
Nomenclature precancer: Journal of oral pathology medicine 2007
http://teachline.ls.huji.ac.il/72320/methods-tutorial/western/western-
blot.html
http://www.bio.davidson.edu/COURSES/GENOMICS/method/westernblot.html
8/2/2019 Diagnostics of Precancerous and Cancerous Lesions
133/133
http://www.bio.davidson.edu/COURSES/GENOMICS/method/Southernblot.html
http://www.med.unc.edu/pmbb/MBT2000/Northern%20Blotting.htm\
http://www.bme.gatech.edu/vcl/WesternBlotting/Background/Introduction.
htm